Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Synthetic Biology Market of Asia Expected to Witness Fastest Growth with 39.8% CAGR During Forecast Period

On the basis of type of segment, the technology segment is expected to be the largest Market and would witness fastest growth during the forecast period. Among the application segment, pharmaceutical and diagnostic had the largest market size in the global market in 2014.

The increasing support from government organizations and growing geriatric population are playing a pivotal role in the growth of this market. Some of the major organizations include National Science Foundation (NSF), National Aeronautics and Space Administration (NASA), Centre for Chemical and Synthetic Biology (CCSB), Synthetic Biology Engineering Research Center (SynBERC), and International Association Synthetic Biology (IASB). These organizations are providing support in form of funding, and initiatives implemented by them for basic and applied research with their respective goals.

Additionally, the innovative and advanced applications of synthetic biology, increasing research activities, and increasing R&D investments in drug discovery and development are also supporting the growth of this market. However stringent regulatory requirements, expensive research procedures, and harmful effects of synthetic biology act as hindrance in the growth of the global market. The growing number of mergers and acquisitions is one of the latest trends observed in this market.

Geographically, North America dominated the global market, among all the regions in 2014; and it is expected to grow with a CAGR of 35.2% during the period 2015 – 2020. However, the Asian market is expected to witness fastest growth, with a CAGR of 39.8% during the forecast period.

The key companies operating in the global Synthetic Biology Market include E. I. du PONT de Nemours and Company, Amyris Inc., GenScript USA Inc., Intrexon Corporation, Thermo Fisher Scientific Inc., Synthetic Genomics Inc., Royal DSM, Novozymes A/S, New England Biolabs Inc., and Integrated DNA Technologies Inc.

News Courtesy: P&S Market Research


Tagged: biopharamaceuticals, biotechnology, healthcare industry, synthetic biology


This post first appeared on Global Industry News, please read the originial post: here

Share the post

Synthetic Biology Market of Asia Expected to Witness Fastest Growth with 39.8% CAGR During Forecast Period

×

Subscribe to Global Industry News

Get updates delivered right to your inbox!

Thank you for your subscription

×